SIREN : 348573874
SARL OSMOSE MEDICALE is a French company founded 37 years ago, specialized in the sector Édition de revues et périodiques. Based in PARIS (75020), this company of category PME shows in 2020 a revenue of 13 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 13 000 € | 147 141 € | N/C | N/C | 77 167 € |
| Net income | 5 411 € | -68 616 € | -10 115 € | -8 310 € | -143 836 € |
| EBITDA | -16 449 € | -61 458 € | -889 € | -577 € | -134 896 € |
| Net margin | 41.6% | -46.6% | N/C | N/C | -186.4% |
In 2020, SARL OSMOSE MEDICALE achieves revenue of 13 k€. Revenue is declining over the period 2016-2020 (CAGR: -35.9%). Significant drop of -91% vs 2019. After deducting consumption (0 €), gross margin stands at 13 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -16 k€, representing -126.5% of revenue. Warning negative scissor effect: despite revenue change (-91%), EBITDA varies by +73%, reducing margin by 84.8 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 5 k€, i.e. 41.6% of revenue. This profit can be retained or distributed to shareholders.
13 000 €
13 000 €
-16 449 €
12 467 €
5 411 €
-126.5%
The debt ratio (= Financial debt / Equity x 100) stands at -107%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -645%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-106.947%
-645.213%
-180.808%
-21.088
In 2020, the debt ratio of SARL OSMOSE MEDICALE (-106.95) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2020, the financial autonomy of SARL OSMOSE MEDICALE (-645.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
In 2020, the repayment capacity of SARL OSMOSE MEDICALE (-21.09) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 181.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
181.232
-42.896
In 2020, the liquidity ratio of SARL OSMOSE MEDICALE (181.23) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2020, the interest coverage of SARL OSMOSE MEDICALE (-42.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 360 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 40 days. The gap of 320 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 572 days of revenue, i.e. 21 k€ to permanently finance. Notable WCR improvement over the period (-78%), freeing up cash.
20 645 €
360 j
40 j
0 j
572 j
Based on 67 transactions of similar company sales
(all years),
the value of SARL OSMOSE MEDICALE is estimated at
13 089 €
(range 3 239€ - 23 964€).
The price/revenue ratio is 0.16x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 67 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SARL OSMOSE MEDICALE with other companies in the same sector:
Voir toutes les statistiques du secteur Édition de revues et périodiques
The revenue of SARL OSMOSE MEDICALE in 2020 is 13 k€.
Yes, SARL OSMOSE MEDICALE generated a net profit of 5 k€ in 2020.
The headquarters of SARL OSMOSE MEDICALE is located in PARIS (75020), in the department Paris.
The tax return of SARL OSMOSE MEDICALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SARL OSMOSE MEDICALE operates in the sector Édition de revues et périodiques (NAF code 58.14Z). See the 'Sector positioning' section above to compare the company with its competitors.